Combined Immunodeficiency
Gene: SMARCAL1
Well-established gene-disease association; over 40 patients with biallelic mutations in SMARCAL1 have been reported; Zebrafish and mouse models that recapitulates phenotype have been reported.
Homozygous and compound heterozygous variants reported include nonsense, frameshift, splice and missense variants.
Primary features include spondyloepiphyseal dysplasia, renal dysfunction, lymphocytopaenia and/or T-cell immunodeficiency.Created: 12 Aug 2021, 12:33 a.m. | Last Modified: 12 Aug 2021, 12:33 a.m.
Panel Version: 0.309
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
Schimke immune-osseous dysplasia MIM# 242900; T cell deficiency; Short stature; spondyloepiphyseal dysplasia; renal dysfunction; lymphocytopaenia; nephropathy; bacterial/viral/fungal infections; may present as SCID; bone marrow failure
Publications
Gene: smarcal1 has been classified as Green List (High Evidence).
Phenotypes for gene: SMARCAL1 were changed from to Schimke immune-osseous dysplasia MIM# 242900; T cell deficiency; Short stature; spondyloepiphyseal dysplasia; renal dysfunction; lymphocytopaenia; nephropathy; bacterial/viral/fungal infections; may present as SCID; bone marrow failure
Publications for gene: SMARCAL1 were set to
Mode of inheritance for gene: SMARCAL1 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal
gene: SMARCAL1 was added gene: SMARCAL1 was added to Combined immunodeficiency_MelbourneGenomics_AustralianGenomics_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services,Melbourne Genomics Health Alliance Immunology Flagship Mode of inheritance for gene: SMARCAL1 was set to Unknown